The Boehringer Ingelheim Foundation and the Board of Trustees will award the 2020 Heinrich Wieland Prize to

Professor Dr Craig M. Crews

Yale University, New Haven, CT, USA

for pioneering targeted protein degradation as a new principle in pharmacology.

Due to the COVID-19 pandemic, the personal presentation of our 2020 award and scientific symposium have been postponed until 2021. Details on the rescheduled event will be published toward the end of the year.

We are pleased to announce that the Boehringer Ingelheim Foundation will hold a virtual event as part of Berlin Science Week 2020, with Professor Craig M. Crews as the guest of honour. Besides introducing the Heinrich Wieland Prize in general and the 2020 laureate in particular, this event will feature a discussion about how ideas spawned from curiosity-driven research can pave the way for new therapeutic approaches and enable the successful founding of science-based start-ups in the US and Germany. At the end of the event, we will invite the audience to participate in a discussion and share their own experiences.

The event titled Starting up science: From lab to therapy will take place on 2 November 2020, from 4:00 p.m. to 5:00 p.m. CET. You can find more information about the virtual event held during Berlin Science Week here.

To learn more about Professor Craig M. Crews, please follow this link.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .